115 related articles for article (PubMed ID: 27046304)
1. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
Jiao C; Zhu A; Jiao X; Ge J; Xu X
J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
Jiao C; Jiao X; Zhu A; Ge J; Xu X
J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
[TBL] [Abstract][Full Text] [Related]
3. Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience.
Qiao GL; Li L; Cheng W; Ge J; Zhang Z; Wei Y
Eur J Surg Oncol; 2014 Nov; 40(11):1533-9. PubMed ID: 25103357
[TBL] [Abstract][Full Text] [Related]
4. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
Liu W; Chen S; Liu B
Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
[TBL] [Abstract][Full Text] [Related]
7. Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
Zhang Z; Shen S
Medicine (Baltimore); 2017 Dec; 96(48):e8795. PubMed ID: 29310356
[TBL] [Abstract][Full Text] [Related]
8. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
[TBL] [Abstract][Full Text] [Related]
9. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
11. MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance.
Ecevit ÇÖ; Aktaş S; Tosun Yildirim H; Demirağ B; Erbay A; Karaca İ; Çelik A; Demir AB; Erçetin AP; Olgun N
J Pediatr Hematol Oncol; 2019 Jan; 41(1):7-12. PubMed ID: 29889802
[TBL] [Abstract][Full Text] [Related]
12. Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer.
Zeng Z; Chen X; Zhu D; Luo Z; Yang M
Yonsei Med J; 2017 Jul; 58(4):697-702. PubMed ID: 28540980
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
[TBL] [Abstract][Full Text] [Related]
14. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and prognostic analysis of hepatoblastoma in children under six years old].
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1063-1068. PubMed ID: 34933424
[No Abstract] [Full Text] [Related]
16. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
17. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C
Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
